Your browser doesn't support javascript.
loading
Exploring the mediation of DNA methylation across the epigenome between childhood adversity and First Episode of Psychosis-findings from the EU-GEI study.
Alameda, Luis; Liu, Zhonghua; Sham, Pak C; Aas, Monica; Trotta, Giulia; Rodriguez, Victoria; Di Forti, Marta; Stilo, Simona A; Kandaswamy, Radhika; Arango, Celso; Arrojo, Manuel; Bernardo, Miguel; Bobes, Julio; de Haan, Lieuwe; Del-Ben, Cristina Marta; Gayer-Anderson, Charlotte; Sideli, Lucia; Jones, Peter B; Jongsma, Hannah E; Kirkbride, James B; La Cascia, Caterina; Lasalvia, Antonio; Tosato, Sarah; Llorca, Pierre-Michel; Menezes, Paulo Rossi; van Os, Jim; Quattrone, Diego; Rutten, Bart P; Santos, Jose Luis; Sanjuán, Julio; Selten, Jean-Paul; Szöke, Andrei; Tarricone, Ilaria; Tortelli, Andrea; Velthorst, Eva; Morgan, Craig; Dempster, Emma; Hannon, Eilis; Burrage, Joe; Dwir, Daniella; Arumuham, Atheeshaan; Mill, Jonathan; Murray, Robin M; Wong, Chloe C Y.
Afiliação
  • Alameda L; Service of General Psychiatry, Treatment and Early Intervention in Psychosis Program, Lausanne University Hospital (CHUV), Lausanne, Switzerland. laluisalameda@gmail.com.
  • Liu Z; Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience. King's College of London, London, UK. laluisalameda@gmail.com.
  • Sham PC; Instituto de Investigación Sanitaria de Sevilla, IbiS, Hospital Universitario Virgen del Rocío, Department of Psychiatry, Universidad de Sevilla, Seville, Spain. laluisalameda@gmail.com.
  • Aas M; Department of Biostatistics, Columbia University, New York, NY, USA.
  • Trotta G; Department of Psychiatry, State Key Laboratory of Brain and Cognitive Sciences, and Centre for PanorOmic Sciences, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pok Fu Lam, Hong Kong.
  • Rodriguez V; Social, Genetics and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
  • Di Forti M; Social, Genetics and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
  • Stilo SA; Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience. King's College of London, London, UK.
  • Kandaswamy R; Social, Genetics and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
  • Arango C; Department of Mental Health and Addiction Services, ASP Crotone, Crotone, Italy.
  • Arrojo M; Social, Genetics and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
  • Bernardo M; Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, School of Medicine, Universidad Complutense, IiSGM, CIBERSAM, Madrid, Spain.
  • Bobes J; Department of Psychiatry, Psychiatric Genetic Group, Instituto de Investigación Sanitaria de Santiago de Compostela, Complejo Hospitalario Universitario de Santiago de Compostela, Santiago, Spain.
  • de Haan L; Barcelona Clinic Schizophrenia Unit, Neuroscience Institute, Hospital Clinic of Barcelona, University of Barcelona, Institut d'Investigacions Biomèdiques August Pi I Sunyer, Biomedical Research Networking Centre in Mental Health (CIBERSAM), Barcelona, Spain.
  • Del-Ben CM; Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain.
  • Gayer-Anderson C; Department of Medicine, Psychiatry Area, School of Medicine, Universidad de Oviedo, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Oviedo, Spain.
  • Sideli L; Department of Psychiatry, Early Psychosis Section, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Jones PB; Neuroscience and Behaviour Department, Ribeirão Preto Medical School, University of São Paulo, São Paulo, Brazil.
  • Jongsma HE; ESRC Centre for Society and Mental Health, King's College London, London, UK.
  • Kirkbride JB; LUMSA University, Department of Human Science and Department of Psychosis Studies, KCL, Rome, Italy.
  • La Cascia C; Department of Psychiatry, University of Cambridge, Cambridge, UK.
  • Lasalvia A; CAMEO Early Intervention Service, Cambridgeshire & Peterborough NHS Foundation Trust, Cambridge, UK.
  • Tosato S; Psylife Group, Division of Psychiatry, University College London, London, UK.
  • Llorca PM; Psylife Group, Division of Psychiatry, University College London, London, UK.
  • Menezes PR; Section of Psychiatry, Department of Biomedicine, Neuroscience and advanced Diagnostic (BiND), University of Palermo, Palermo, Italy.
  • van Os J; Section of Psychiatry, Department of Neuroscience, Biomedicine and Movement, University of Verona, Verona, Italy.
  • Quattrone D; Section of Psychiatry, Department of Neuroscience, Biomedicine and Movement, University of Verona, Verona, Italy.
  • Rutten BP; Université Clermont Auvergne, Clermont-Ferrand, France.
  • Santos JL; Department of Preventive Medicine, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil.
  • Sanjuán J; Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience. King's College of London, London, UK.
  • Selten JP; Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, South Limburg Mental Health Research and Teaching Network, Maastricht University Medical Centre, Maastricht, The Netherlands.
  • Szöke A; Department Psychiatry, Brain Centre Rudolf Magnus, Utrecht University Medical Centre, Utrecht, The Netherlands.
  • Tarricone I; Social, Genetics and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
  • Tortelli A; Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, South Limburg Mental Health Research and Teaching Network, Maastricht University Medical Centre, Maastricht, The Netherlands.
  • Velthorst E; Department of Psychiatry, Servicio de Psiquiatría Hos"ital "Virgen de"a Luz", C/Hermandad de Donantes de Sangre, 16002, Cuenca, Spain.
  • Morgan C; Department of Psychiatry, School of Medicine, Universidad de Valencia, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), C/Avda. Blasco Ibáñez 15, 46010, Valencia, Spain.
  • Dempster E; Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, South Limburg Mental Health Research and Teaching Network, Maastricht University Medical Centre, Maastricht, The Netherlands.
  • Hannon E; Rivierduinen Institute for Mental Health Care, Leiden, The Netherlands.
  • Burrage J; University of Paris Est Creteil, INSERM, IMRB, AP-HP, Hôpitaux Universitaires, H. Mondor, DMU IMPACT, Creteil, France.
  • Dwir D; Bologna Transcultural Psychosomatic Team (BoTPT), Department of Medical and Surgical Science, Alma Mater Studiorum Università di Bologna, Bologna, Italy.
  • Arumuham A; Institute Mondor de recherché biomedicale, Creteil, France.
  • Mill J; GGZ (Mental Health Services) Noord Holland Noord, Heerhugowaard, the Netherlands.
  • Murray RM; ESRC Centre for Society and Mental Health, King's College London, London, UK.
  • Wong CCY; Department of Psychiatry, Center for Psychiatric Neuroscience, Lausanne University Hospital (CHUV), Lausanne, Switzerland.
Mol Psychiatry ; 28(5): 2095-2106, 2023 May.
Article em En | MEDLINE | ID: mdl-37062770
ABSTRACT
ABTRACT Studies conducted in psychotic disorders have shown that DNA-methylation (DNAm) is sensitive to the impact of Childhood Adversity (CA). However, whether it mediates the association between CA and psychosis is yet to be explored. Epigenome wide association studies (EWAS) using the Illumina Infinium-Methylation EPIC array in peripheral blood tissue from 366 First-episode of psychosis and 517 healthy controls was performed. Adversity scores were created for abuse, neglect and composite adversity with the Childhood Trauma Questionnaire (CTQ). Regressions examining (I) CTQ scores with psychosis; (II) with DNAm EWAS level and (III) between DNAm and caseness, adjusted for a variety of confounders were conducted. Divide-Aggregate Composite-null Test for the composite null-hypothesis of no mediation effect was conducted. Enrichment analyses were conducted with missMethyl package and the KEGG database. Our results show that CA was associated with psychosis (Composite OR = 1.68; p = <0.001; abuse OR = 2.16; p < 0.001; neglect OR = 2.27; p = <0.001). None of the CpG sites significantly mediated the adversity-psychosis association after Bonferroni correction (p < 8.1 × 10-8). However, 28, 34 and 29 differentially methylated probes associated with 21, 27, 20 genes passed a less stringent discovery threshold (p < 5 × 10-5) for composite, abuse and neglect respectively, with a lack of overlap between abuse and neglect. These included genes previously associated to psychosis in EWAS studies, such as PANK1, SPEG TBKBP1, TSNARE1 or H2R. Downstream gene ontology analyses did not reveal any biological pathways that survived false discovery rate correction. Although at a non-significant level, DNAm changes in genes previously associated with schizophrenia in EWAS studies may mediate the CA-psychosis association. These results and associated involved processes such as mitochondrial or histaminergic disfunction, immunity or neural signalling requires replication in well powered samples. The lack of overlap between mediating genes associated with abuse and neglect suggests differential biological trajectories linking CA subtypes and psychosis.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Testes Psicológicos / Transtornos Psicóticos / Autorrelato / Experiências Adversas da Infância Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Child / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Testes Psicológicos / Transtornos Psicóticos / Autorrelato / Experiências Adversas da Infância Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Child / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article